Af­ter years of de­lay, BeiGene fi­nal­ly lands FDA ap­proval for its PD-1 drug

BeiGene has won the first FDA ap­proval for its PD-1 in­hibitor, mark­ing a hard-earned mile­stone af­ter a wind­ing reg­u­la­to­ry jour­ney that be­gan two and a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

Director of IT, Security

Viridian Therapeutics

Waltham, MA, USA